US Stock MarketDetailed Quotes

BIIB Biogen

Watchlist
  • 147.590
  • +0.800+0.54%
Trading Dec 19 13:54 ET
21.51BMarket Cap13.34P/E (TTM)

Biogen Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
57.93%935.6M
28.50%625.8M
21.50%553.2M
11.77%1.55B
107.14%12.5M
-10.38%592.4M
-33.88%487M
181.40%455.3M
-61.97%1.38B
-120.88%-175M
Net income from continuing operations
668.81%388.5M
-1.63%583.6M
1.50%393.4M
-60.78%1.16B
-54.70%248.9M
-106.02%-68.3M
-43.96%593.3M
77.39%387.6M
71.43%2.96B
2,780.49%549.5M
Operating gains losses
-112.86%-38.9M
45.21%-58.3M
-60.68%31.3M
115.87%277.1M
-98.67%1.4M
149.37%302.5M
92.58%-106.4M
-59.05%79.6M
-320.46%-1.75B
7.10%105.6M
Depreciation and amortization
46.24%182.8M
35.35%158.9M
31.34%147.5M
-4.55%494.8M
16.94%140.1M
3.56%125M
-12.91%117.4M
-21.52%112.3M
6.29%518.4M
-11.06%119.8M
Deferred tax
74.56%-52.6M
18.23%-87M
161.86%39.9M
-81.38%-305.8M
349.65%71.9M
-124.05%-206.8M
-119.38%-106.4M
-6,550.00%-64.5M
60.50%-168.6M
-108.91%-28.8M
Other non cash items
103.63%129.1M
202.27%146.6M
98.77%97M
-9.31%304.1M
219.10%143.4M
28.08%63.4M
-45.20%48.5M
-84.64%48.8M
-0.53%335.3M
-172.01%-120.4M
Change In working capital
-25.64%233.8M
-44.08%-188.6M
-24.23%-228.7M
27.14%-648.7M
34.37%-648.1M
11,744.44%314.4M
-114.87%-130.9M
76.41%-184.1M
-511.89%-890.3M
-1,395.93%-987.5M
-Change in receivables
229.38%114.5M
12.54%-87.2M
-26.48%84.4M
125.49%56.7M
218.38%130.1M
-309.72%-88.5M
-279.09%-99.7M
277.71%114.8M
-168.22%-222.4M
-171.04%-109.9M
-Change in inventory
-163.58%-19.2M
-18.82%-110.5M
-378.49%-77.7M
59.12%-130.9M
-630.39%-96M
131.79%30.2M
7.65%-93M
119.57%27.9M
30.75%-320.2M
112.95%18.1M
-Change in payables and accrued expense
-92.54%31.4M
-63.37%61.5M
39.97%-177.1M
-77.78%-201.6M
33.55%-495.5M
24,864.71%421M
-84.68%167.9M
36.09%-295M
-18.87%-113.4M
-604.19%-745.7M
-Change in other working capital
321.74%107.1M
50.61%-52.4M
-83.33%-58.3M
-59.15%-372.9M
-24.47%-186.7M
-141.78%-48.3M
-20.29%-106.1M
71.53%-31.8M
-371.49%-234.3M
-73.21%-150M
Cash from discontinued investing activities
Operating cash flow
57.93%935.6M
28.50%625.8M
21.50%553.2M
11.77%1.55B
107.14%12.5M
-10.38%592.4M
-33.88%487M
181.40%455.3M
-61.97%1.38B
-120.88%-175M
Investing cash flow
Cash flow from continuing investing activities
32.21%-1.18B
161.91%466.5M
93.07%-66M
-360.12%-4.1B
-362.30%-652.3M
-204.19%-1.74B
-208.65%-753.5M
-47.07%-953M
379.69%1.58B
-25.20%-141.1M
Net PPE purchase and sale
52.83%-35M
52.82%-33.5M
31.08%-45.9M
-180.92%-277M
24.54%-65.2M
-114.17%-74.2M
-92.41%-71M
-15.03%-66.6M
232.62%342.3M
-67.44%-86.4M
Net intangibles purchase and sale
-716.42%-109.4M
686.88%93.9M
-1,400.00%-75M
-1,086.21%-34.4M
--0
---13.4M
-742.11%-16M
---5M
92.12%-2.9M
94.08%-1M
Net business purchase and sale
83.04%-1.07B
----
----
-719.81%-6.14B
---590.5M
---6.34B
----
----
3,424.20%990.3M
--0
Net investment purchase and sale
-99.16%39.2M
100.13%1.9M
106.31%55.6M
960.54%2.36B
117.56%13.4M
307.45%4.68B
-458.88%-1.45B
-49.30%-880.7M
171.82%222.5M
-35.04%-76.3M
Net other investing changes
-450.00%-1.1M
-550.00%-2.6M
0.00%-700K
-146.31%-11.3M
-144.25%-10M
0.00%-200K
-118.18%-400K
-250.00%-700K
89.15%24.4M
83.74%22.6M
Cash from discontinued investing activities
Investing cash flow
32.21%-1.18B
161.91%466.5M
93.07%-66M
-360.12%-4.1B
-362.30%-652.3M
-204.19%-1.74B
-208.65%-753.5M
-47.07%-953M
379.69%1.58B
-25.20%-141.1M
Financing cash flow
Cash flow from continuing financing activities
-100.78%-6.6M
-2,402.04%-245.2M
-912.90%-439.6M
108.54%149.3M
-8,631.08%-646.1M
167.78%848.6M
97.92%-9.8M
-163.03%-43.4M
16.24%-1.75B
-175.51%-7.4M
Net issuance payments of debt
--0
---250M
---400M
118.69%187.3M
---650M
--837.3M
--0
--0
-489.53%-1B
--0
Net common stock issuance
----
----
----
--0
----
----
----
----
58.33%-750M
--0
Proceeds from stock option exercised by employees
-9.09%6M
10.91%6.1M
21.96%-46.9M
-2,231.58%-44.3M
-5.13%3.7M
15.79%6.6M
-40.86%5.5M
-188.94%-60.1M
-171.43%-1.9M
-48.68%3.9M
Net other financing activities
-368.09%-12.6M
91.50%-1.3M
-56.29%7.3M
-7.35%6.3M
101.77%200K
187.04%4.7M
-179.69%-15.3M
288.37%16.7M
105.89%6.8M
-613.64%-11.3M
Cash from discontinued financing activities
Financing cash flow
-100.78%-6.6M
-2,402.04%-245.2M
-912.90%-439.6M
108.54%149.3M
-8,631.08%-646.1M
167.78%848.6M
97.92%-9.8M
-163.03%-43.4M
16.24%-1.75B
-175.51%-7.4M
Net cash flow
Beginning cash position
-27.08%1.91B
-62.93%1.07B
-69.29%1.05B
51.20%3.42B
-37.75%2.29B
-1.09%2.62B
65.68%2.9B
51.20%3.42B
69.88%2.26B
138.40%3.68B
Current changes in cash
16.30%-252.1M
406.59%847.1M
108.80%47.6M
-298.13%-2.4B
-297.50%-1.29B
-127.86%-301.2M
-128.83%-276.3M
-7.64%-541.1M
22.59%1.21B
-143.99%-323.5M
Effect of exchange rate changes
247.74%42.4M
-207.32%-12.6M
-215.50%-23.1M
163.02%35.1M
-28.72%47.9M
45.12%-28.7M
93.30%-4.1M
312.77%20M
6.86%-55.7M
525.32%67.2M
End cash Position
-25.73%1.7B
-27.08%1.91B
-62.93%1.07B
-69.29%1.05B
-69.29%1.05B
-37.75%2.29B
-1.09%2.62B
65.68%2.9B
51.20%3.42B
51.20%3.42B
Free cash flow
59.59%805.6M
45.80%583.2M
12.67%432.3M
8.30%1.24B
79.92%-52.7M
-16.13%504.8M
-42.67%400M
269.30%383.7M
-65.89%1.14B
-134.09%-262.4M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 57.93%935.6M28.50%625.8M21.50%553.2M11.77%1.55B107.14%12.5M-10.38%592.4M-33.88%487M181.40%455.3M-61.97%1.38B-120.88%-175M
Net income from continuing operations 668.81%388.5M-1.63%583.6M1.50%393.4M-60.78%1.16B-54.70%248.9M-106.02%-68.3M-43.96%593.3M77.39%387.6M71.43%2.96B2,780.49%549.5M
Operating gains losses -112.86%-38.9M45.21%-58.3M-60.68%31.3M115.87%277.1M-98.67%1.4M149.37%302.5M92.58%-106.4M-59.05%79.6M-320.46%-1.75B7.10%105.6M
Depreciation and amortization 46.24%182.8M35.35%158.9M31.34%147.5M-4.55%494.8M16.94%140.1M3.56%125M-12.91%117.4M-21.52%112.3M6.29%518.4M-11.06%119.8M
Deferred tax 74.56%-52.6M18.23%-87M161.86%39.9M-81.38%-305.8M349.65%71.9M-124.05%-206.8M-119.38%-106.4M-6,550.00%-64.5M60.50%-168.6M-108.91%-28.8M
Other non cash items 103.63%129.1M202.27%146.6M98.77%97M-9.31%304.1M219.10%143.4M28.08%63.4M-45.20%48.5M-84.64%48.8M-0.53%335.3M-172.01%-120.4M
Change In working capital -25.64%233.8M-44.08%-188.6M-24.23%-228.7M27.14%-648.7M34.37%-648.1M11,744.44%314.4M-114.87%-130.9M76.41%-184.1M-511.89%-890.3M-1,395.93%-987.5M
-Change in receivables 229.38%114.5M12.54%-87.2M-26.48%84.4M125.49%56.7M218.38%130.1M-309.72%-88.5M-279.09%-99.7M277.71%114.8M-168.22%-222.4M-171.04%-109.9M
-Change in inventory -163.58%-19.2M-18.82%-110.5M-378.49%-77.7M59.12%-130.9M-630.39%-96M131.79%30.2M7.65%-93M119.57%27.9M30.75%-320.2M112.95%18.1M
-Change in payables and accrued expense -92.54%31.4M-63.37%61.5M39.97%-177.1M-77.78%-201.6M33.55%-495.5M24,864.71%421M-84.68%167.9M36.09%-295M-18.87%-113.4M-604.19%-745.7M
-Change in other working capital 321.74%107.1M50.61%-52.4M-83.33%-58.3M-59.15%-372.9M-24.47%-186.7M-141.78%-48.3M-20.29%-106.1M71.53%-31.8M-371.49%-234.3M-73.21%-150M
Cash from discontinued investing activities
Operating cash flow 57.93%935.6M28.50%625.8M21.50%553.2M11.77%1.55B107.14%12.5M-10.38%592.4M-33.88%487M181.40%455.3M-61.97%1.38B-120.88%-175M
Investing cash flow
Cash flow from continuing investing activities 32.21%-1.18B161.91%466.5M93.07%-66M-360.12%-4.1B-362.30%-652.3M-204.19%-1.74B-208.65%-753.5M-47.07%-953M379.69%1.58B-25.20%-141.1M
Net PPE purchase and sale 52.83%-35M52.82%-33.5M31.08%-45.9M-180.92%-277M24.54%-65.2M-114.17%-74.2M-92.41%-71M-15.03%-66.6M232.62%342.3M-67.44%-86.4M
Net intangibles purchase and sale -716.42%-109.4M686.88%93.9M-1,400.00%-75M-1,086.21%-34.4M--0---13.4M-742.11%-16M---5M92.12%-2.9M94.08%-1M
Net business purchase and sale 83.04%-1.07B---------719.81%-6.14B---590.5M---6.34B--------3,424.20%990.3M--0
Net investment purchase and sale -99.16%39.2M100.13%1.9M106.31%55.6M960.54%2.36B117.56%13.4M307.45%4.68B-458.88%-1.45B-49.30%-880.7M171.82%222.5M-35.04%-76.3M
Net other investing changes -450.00%-1.1M-550.00%-2.6M0.00%-700K-146.31%-11.3M-144.25%-10M0.00%-200K-118.18%-400K-250.00%-700K89.15%24.4M83.74%22.6M
Cash from discontinued investing activities
Investing cash flow 32.21%-1.18B161.91%466.5M93.07%-66M-360.12%-4.1B-362.30%-652.3M-204.19%-1.74B-208.65%-753.5M-47.07%-953M379.69%1.58B-25.20%-141.1M
Financing cash flow
Cash flow from continuing financing activities -100.78%-6.6M-2,402.04%-245.2M-912.90%-439.6M108.54%149.3M-8,631.08%-646.1M167.78%848.6M97.92%-9.8M-163.03%-43.4M16.24%-1.75B-175.51%-7.4M
Net issuance payments of debt --0---250M---400M118.69%187.3M---650M--837.3M--0--0-489.53%-1B--0
Net common stock issuance --------------0----------------58.33%-750M--0
Proceeds from stock option exercised by employees -9.09%6M10.91%6.1M21.96%-46.9M-2,231.58%-44.3M-5.13%3.7M15.79%6.6M-40.86%5.5M-188.94%-60.1M-171.43%-1.9M-48.68%3.9M
Net other financing activities -368.09%-12.6M91.50%-1.3M-56.29%7.3M-7.35%6.3M101.77%200K187.04%4.7M-179.69%-15.3M288.37%16.7M105.89%6.8M-613.64%-11.3M
Cash from discontinued financing activities
Financing cash flow -100.78%-6.6M-2,402.04%-245.2M-912.90%-439.6M108.54%149.3M-8,631.08%-646.1M167.78%848.6M97.92%-9.8M-163.03%-43.4M16.24%-1.75B-175.51%-7.4M
Net cash flow
Beginning cash position -27.08%1.91B-62.93%1.07B-69.29%1.05B51.20%3.42B-37.75%2.29B-1.09%2.62B65.68%2.9B51.20%3.42B69.88%2.26B138.40%3.68B
Current changes in cash 16.30%-252.1M406.59%847.1M108.80%47.6M-298.13%-2.4B-297.50%-1.29B-127.86%-301.2M-128.83%-276.3M-7.64%-541.1M22.59%1.21B-143.99%-323.5M
Effect of exchange rate changes 247.74%42.4M-207.32%-12.6M-215.50%-23.1M163.02%35.1M-28.72%47.9M45.12%-28.7M93.30%-4.1M312.77%20M6.86%-55.7M525.32%67.2M
End cash Position -25.73%1.7B-27.08%1.91B-62.93%1.07B-69.29%1.05B-69.29%1.05B-37.75%2.29B-1.09%2.62B65.68%2.9B51.20%3.42B51.20%3.42B
Free cash flow 59.59%805.6M45.80%583.2M12.67%432.3M8.30%1.24B79.92%-52.7M-16.13%504.8M-42.67%400M269.30%383.7M-65.89%1.14B-134.09%-262.4M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Cancer Research
Cancer Research
Intraday+0.19%